Prestige Consumer Healthcare Inc.
Financial Performance
Prestige Consumer Healthcare Revenue & Financials
Revenue
$1.1B (FY2026)
Market Cap
$2.2B
Net Income
$190.3M
Employees
890
What is Prestige Consumer Healthcare's revenue?
Prestige Consumer Healthcare had $1.1B in revenue for fiscal year 2026, down 4.3% from 2025. Net income was $190.3M.
- Latest revenue
- $1.1B (FY2026)
- Year-over-year
- -4.3%
- Growth rate (CAGR)
- 2.4% over 9 years
- Peak revenue
- $1.1B (FY2025)
- Years of data
- 10
- Employees
- 890
- What is Prestige Consumer Healthcare's operating income?
- Prestige Consumer Healthcare reported operating income of $309.4M for fiscal year 2026. sec.gov
- How much profit does Prestige Consumer Healthcare make?
- Prestige Consumer Healthcare reported net income of $190.3M for fiscal year 2026. sec.gov
- How many employees does Prestige Consumer Healthcare have?
- Prestige Consumer Healthcare has about 890 employees.
Financial Analysis
Revenue has hovered around $1.1 billion since FY2022: $1.087 billion in FY2022, $1.128 billion in FY2023, $1.125 billion in FY2024, $1.138 billion in FY2025 and $1.089 billion in FY2026. The FY2026 decline of 4.3% came mainly from limited Clear Eyes supply plus fourth-quarter Middle East shipping disruptions, while Fleet, Dramamine and Hydralyte grew. FY2026 diluted EPS was $3.91 ($4.38 adjusted) and free cash flow was $246.4 million. In Q1 FY2027 (quarter ended June 30, 2026) revenue rose 6.5% to $265.7 million, including $5.9 million from Breathe Right, with diluted EPS of $0.61 and adjusted EPS of $0.98. Management raised FY2027 revenue guidance to $1.29-$1.315 billion and adjusted EPS to $4.55-$4.65 to include the acquisitions, which were funded partly with a $400 million senior notes offering.
Revenue Trend Analysis
YoY Change
-4.3%
9-Year CAGR
+2.4%
Peak Year
2025
Trend
Volatile
Prestige Consumer Healthcare Inc. has 10 full fiscal year figures on this page, compounding at +2.4% annually over 9 years. The most recent year saw a 4.3% decline versus the prior year. Annual revenue peaked in fiscal year 2025 at $1.1B. Of 9 comparable year-over-year steps, 4 showed growth and 5 showed a decline.
Annual revenue history
Click any row to see year details.
Prestige Consumer Healthcare Inc. balance sheet and cash flow
Balance-sheet figures are as of each fiscal year end; cash-flow figures cover the fiscal year. Taken from the company's annual report on Form 10-K, linked on each row. Free cash flow here is operating cash flow less capital expenditures, calculated by CorpDigest.
| Fiscal Year | Operating cash flow | Capital expenditures | Total assets | Total liabilities | Shareholders' equity | Free cash flow | Source |
|---|---|---|---|---|---|---|---|
| FY2026ended Mar 31, 2026 | $257.6M | $11.2M | $3.5B | $1.6B | $1.9B | $246.4M | Form 10-K |
| FY2025ended Mar 31, 2025 | $251.5M | $8.2M | $3.4B | $1.6B | $1.8B | $243.3M | Form 10-K |
| FY2024ended Mar 31, 2024 | $248.9M | $9.6M | $3.3B | $1.7B | $1.7B | $239.4M | Form 10-K |
| FY2023ended Mar 31, 2023 | $229.7M | $7.8M | $3.4B | $1.9B | $1.4B | $221.9M | Form 10-K |
| FY2022ended Mar 31, 2022 | $259.9M | $9.6M | $3.7B | $2.1B | $1.6B | $250.3M | Form 10-K |
| FY2021ended Mar 31, 2021 | $235.6M | $22.2M | $3.4B | $2.1B | $1.4B | $213.4M | Form 10-K |
| FY2020ended Mar 31, 2020 | $217.1M | $14.6M | $3.5B | $2.3B | $1.2B | $202.6M | Form 10-K |
| FY2019ended Mar 31, 2019 | $189.3M | $10.5M | $3.4B | $2.3B | $1.1B | $178.8M | Form 10-K |
| FY2018ended Mar 31, 2018 | $210.1M | $12.5M | $3.8B | $2.6B | $1.2B | $197.6M | Form 10-K |
| FY2017ended Mar 31, 2017 | $148.7M | $3M | $3.9B | $3.1B | $822.5M | $145.7M | Form 10-K |
Keep researching Prestige Consumer Healthcare
Prestige Consumer Healthcare Revenue and Financial FAQ
What is Prestige Consumer Healthcare's annual revenue?
FY2026 revenue was $1.089 billion, down 4.3% from $1.138 billion in FY2025. Net income was $190.3 million.
What is Prestige's free cash flow?
Free cash flow was $246.4 million in FY2026, up 1.3% from the prior year.
What is Prestige's FY2027 outlook?
After the Breathe Right and LaCorium deals, management guided FY2027 revenue to $1.29-$1.315 billion and adjusted EPS to $4.55-$4.65.
How did Prestige perform in Q1 FY2027?
Revenue rose 6.5% to $265.7 million, including $5.9 million from Breathe Right; diluted EPS was $0.61 and adjusted EPS $0.98.
What is Prestige's free cash flow generation and debt de-leveraging strategy?
Prestige generates over $220 million to $250 million in annual free cash flow (a free cash flow conversion rate near 100% of net income). The company uses this predictable cash flow to pay down acquisition debt, reducing leverage ratios below 3.0x EBITDA, before deploying capital into share repurchases.
What was the financial impact of the 2024 Clear Eyes supply chain disruption?
In fiscal 2024, a major third-party contract manufacturing supplier for Clear Eyes eye drops experienced regulatory compliance delays, temporarily reducing product availability on store shelves and lowering annual segment revenues by ~$30 million before supply normalized in 2025.
How does Prestige allocate capital between M&A and share buybacks?
Prestige maintains a disciplined financial framework: in the absence of attractively priced, accretive OTC brand acquisition targets, the company directs virtually all excess free cash flow toward repurchasing its NYSE-listed common shares (ticker: PBH).
What is Prestige's long-term organic revenue growth target?
Prestige targets steady, low-single-digit organic annual revenue growth (2% to 3%), driven by modest population growth, an aging demographic requiring eye and gastrointestinal care, and incremental price-pack optimization.
Cite or embed this data
Using these figures? Please credit CorpDigest with a link.
CorpDigest. "Prestige Consumer Healthcare Revenue & Financials." CorpDigest, https://corpdigest.com/company/prestige-consumer/financials.<div style="font-family:system-ui,sans-serif;font-size:14px;line-height:1.5;border:1px solid #e2e8f0;border-radius:8px;padding:12px 16px;max-width:520px"><strong>Prestige Consumer Healthcare reported $1.1B in revenue (FY2026).</strong><br>Source: <a href="https://corpdigest.com/company/prestige-consumer/financials" target="_blank" rel="noopener">CorpDigest — Prestige Consumer Healthcare financials</a></div>Related Financial Audits
Compare revenue, net income, and market cap scale
Explore Prestige Consumer Healthcare
Core profile pages, founders and related research hubs for this company.